Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E

计划入组 38 人 · 首次发布于 2008 年 9 月 29 日

aproxen tablet bioequivalence

计划入组 24 人

Efficacy of Naproxen-codeine, Naproxen+Dexamethasone, and Naproxen on Myofascial Pain

计划入组 200 人 · 首次发布于 2019 年 8 月 26 日

AP20 (Aprogen)

Adalimumab biosimilar(Aprogen)

DAAP (Aprogen, Inc.)

AEROGEN PHARMA LIMITED

Ireland

Progen Co., Ltd.

South Korea

Alvogen, Inc.

United States

Aprogen to Hold FDA Meeting for Herceptin Biosimilar AP063 Approval

Aprogen's Herceptin Biosimilar AP-063 Advances to Regulatory Approval Without Phase 3 Trials

Aprogen Advances AP209, a Bispecific Receptor Osteoarthritis Drug, into Phase 1 Clinical Trials Following South Korean IND Approval